sonata 5 mg hard capsules kõvakapsel
meda ab - zaleploon - kõvakapsel - 5mg 100tk
phenobarbital sodium süstelahus
sterop overseas s.a. laboratories - fenobarbitaal - süstelahus - 100mg 1ml 1ml 100tk
mirataz
dechra regulatory b.v. - mirtazapine - psychoanaleptics, antidepressants in combination with psycholeptics - kassid - näiteks kehakaalu suurenemine kassid tekkinud isutus ja kaalu kaotus, mis tulenevad kroonilised haigusseisundid.
ayvakyt
blueprint medicines (netherlands) b.v. - avapritinib - seedetraktist esinevad stromaal-kasvajad - muud antineoplastilised ained, protein kinase inhibiitorid - ayvakyt is indicated as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours (gist) harbouring the platelet-derived growth factor receptor alpha (pdgfra) d842v mutation.
phenotab flavoured tablett
cp-pharma handelsgesellschaft mbh - fenobarbitaal - tablett - 60mg 100tk
phenotab flavoured tablett
cp-pharma handelsgesellschaft mbh - fenobarbitaal - tablett - 25mg 100tk
phenotab flavoured tablett
cp-pharma handelsgesellschaft mbh - fenobarbitaal - tablett - 100mg 100tk
vocabria
viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv-nakkused - viirusevastased ravimid süsteemseks kasutamiseks - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.
rekambys
janssen-cilag international nv - rilpivirine - hiv-nakkused - viirusevastased ravimid süsteemseks kasutamiseks - rekambys is indicated, in combination with cabotegravir injection, for the treatment of human immunodeficiency virus type 1 (hiv 1) infection in adults who are virologically suppressed (hiv-1 rna < 50 copies/ml) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with, agents of the nnrti and ini class.
jcovden (previously covid-19 vaccine janssen)
janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - vaktsiinid - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.